Thrombectomy Devices Market Report 2026

Thrombectomy Devices Market Overview

• Thrombectomy Devices market size has reached to $1.64 billion in 2025 • Expected to grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Rising Aging Population Is Anticipated To Fuel Thrombectomy Devices Market • Market Trend: Arterial Thrombectomy Systems Reshaping The Thrombectomy Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Thrombectomy Devices Market?

Thrombectomy devices refer to vacuum aspiration to remove the occlusive clot in acute ischemic stroke. Surgical thrombectomy includes pulling or sucking out the clot with a specially developed clot removal device introduced through a catheter to restore blood flow. The main product types of thrombectomy devices are aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices, and others. Aspiration thrombectomy devices are medical devices used to remove blood clots or thrombi from blood vessels. These are used in various applications such as cardiovascular applications, peripheral applications, and neurovascular applications and are used by hospitals, surgical centers, ambulatory, academia, and contract research organizations (CROS).

What Is The Thrombectomy Devices Market Growth Forecast?

The thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of thrombectomy in wider patient populations, growing demand for faster reperfusion outcomes, expansion of advanced neurovascular infrastructure, rising investments in next-generation thrombectomy devices, increasing focus on combination therapy approaches. Major trends in the forecast period include increasing adoption of aspiration-based thrombectomy techniques, rising use of stent retriever devices, growing focus on rapid stroke intervention protocols, expansion of minimally invasive neurovascular procedures, enhanced device precision and trackability.

Global Thrombectomy Devices Market Segmentation

1) By Product Type: Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices 2) By Application: Neurovascular Applications, Peripheral Vascular Applications, Cardiovascular Applications 3) By End-User: Hospitals, Comprehensive Stroke Centers, Tertiary Care Centers Subsegments: 1) By Aspiration Thrombectomy Devices: Manual Aspiration Devices, Powered Aspiration Devices 2) By Mechanical Thrombectomy Devices: Stent Retriever Devices, Balloon Thrombectomy Devices

What Is The Driver Of The Thrombectomy Devices Market?

The rising aging population is expected to propel the growth of the thrombectomy devices market going forward. An aging population refers to a demographic shift characterized by an increasing proportion of elderly individuals within a society over time. Thrombectomy devices play a crucial role in addressing various health concerns in the aging population such as stroke, coronary artery disease, aortic thrombosis, deep vein thrombosis (DVT), and others. For instance, in October 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, by 2030, one in six people globally will be aged 60 or older, with the population of individuals in this age group projected to double to 2.1 billion by 2050. Therefore, the rising aging population is driving the foot orthotic insoles market.

Key Players In The Global Thrombectomy Devices Market

Major companies operating in the thrombectomy devices market are Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Penumbra Inc., Abbott Laboratories, Inari Medical Inc., BTG International Ltd., Phenox GmbH, Acandis GmbH & Co. KG, Straub Medical AG, MicroVention Inc., Rapid Medical, Neuravi Limited, Arteria Therapeutics Inc., Johnson and Johnson, Edwards Lifesciences Corporation, Argon Medical Devices Inc., Teleflex Incorporated, AngioDynamics, Koninklijke Philips NV, Spectranetics Corporation, C. R. Bard Inc., Walk Vascular LLC, Kaneka Corporation, Baxter International

Global Thrombectomy Devices Market Trends and Insights

Major companies operating in the thrombectomy devices market are focused on developing innovative solutions such as arterial thrombectomy system. An arterial thrombectomy system is a medical device designed for the removal of blood clots (thrombi) from arteries. For instance, in June 2023, Penumbra, Inc., a US-based healthcare company announced the launch of ‘Lightning Bolt 7’. Lightning Bolt 7 is the new arterial thrombectomy system that is used to remove the blood clots from the arteries. The system is integrated with the pressure sensors paired with an algorithm to remove large and fibrous blood clots in the arteries with minimal blood loss. It is used to address the conditions where a blockage restricts blood flow to the intestines, spleen, limbs, and liver. The incorporation of computer-aided components not only enhances safety but, when coupled with the rapid and efficient clot removal, encourages a preference for an endovascular-first approach in a wider range of cases, prioritizing it over open surgery.

What Are Latest Mergers And Acquisitions In The Thrombectomy Devices Market?

In May 2024, GTCR, a US-based private equity firm, acquired Surmodics for an undisclosed amount. Through this acquisition, GTCR aims to strengthen Surmodics' growth, support its innovation in medical technologies, provide value to shareholders, and leverage synergies to enhance market reach while transitioning the company to a private structure for a more strategic focus. Surmodics is a US-based company specializing in drug delivery technologies, in vitro diagnostic (IVD) products, medical device coatings, and thrombectomy devices.

Regional Outlook

North America was the largest region in the thrombectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global thrombectomy devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Thrombectomy Devices Market?

The thrombectomy devices market consists of sales of mechanical thrombectomy, and aspiration thrombectomy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.